Andere Sprachen Otsuka Holdings Co., Ltd.

Aktien

A1C9KC

JP3188220002

4578

Verzögert Japan Exchange Andere Börsenplätze 04:43:14 07.12.2023			% 5 Tage	% 1. Jan.
5.729 ^JPY	-0,49 %		+0,70 %	+33,08 %

05.12.	Otsuka-Einheit kauft New Yorker Anbieter von Frauengesundheitsprodukten	MT
29.11.	OTSUKA HOLDINGS CO., LTD. : Nomura bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Tokyo ouvre en rebond grâce à la détente des taux obligataires	06.12.
Otsuka Unit Buys New York-Based Provider of Women Health Products	05.12.
Jefferies: Investor Interest Shifts from Daiichi Sankyo to Chugai and Otsuka Holdings	27.11.
US FDA approves Medtronic's blood pressure treatment device for use	18.11.
Aurinia Pharmaceuticals Partner Otsuka Pharmaceutical Files New Drug Application For Voclosporin in Japan	13.11.
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy	10.11.
FDA Approves Otsuka's Innovative Paradise Ultrasound System for Hypertension Treatment	09.11.
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension	08.11.
US FDA approves Otsuka's blood pressure treatment device for use	08.11.
Otsuka Holdings’ Attributable Profit up 45.6% in Nine-Month Period as Revenue Growth More than Offsets Impairment Losses	01.11.
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	31.10.
Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023	26.10.
Lupin Gets US FDA Final Nod for Tolvaptan Tablets	06.10.
El Nikkei cae un 0,5%, arrastrado por los valores minoristas y farmacéuticos -- Market Talk	22.09.
Mindset Pharma Agrees to be Bought by Otsuka Pharmaceutical	31.08.
Otsuka's Paradise Renal Denervation Device Receives Favorable Pre-Market Approval Votes from FDA Panel	24.08.
Renova Signs 30-Year Purchase Agreement to Sell Non-FIT Non-Fossil Certs to Otsuka	24.08.
US FDA panel votes against use of Medtronic's blood pressure treatment device	24.08.
Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension	23.08.
US FDA panel backs Otsuka's blood pressure treatment device	22.08.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Otsuka Holdings Co., Ltd.

Aktien

A1C9KC

JP3188220002

4578

Andere Sprachen

Filter